Skip to main content

Bulls on Parade as Fundamentals Matter

Good news from a number of firms sends shares sharply higher. Chris Edmonds opines on OPEC's surprise, plus Adam Feuerstein on ImClone, Amgen and biotech.
  • Author:
  • Publish date:


Aaron L. Task is editor at large of In keeping with TSC's editorial policy, he doesn't own or short individual stocks, although he owns stock in He also doesn't invest in hedge funds or other private investment partnerships. He appreciates your feedback;

click here

to send him an email.

Scroll to Continue

TheStreet Recommends